HC Wainwright Comments on Edesa Biotech Q2 Earnings
Edesa Biotech, Inc. (NASDAQ:EDSA – Free Report) – Equities research analysts at HC Wainwright issued their Q2 2025 earnings estimates for shares of Edesa Biotech in a research report issued to clients and investors on Thursday, March 13th. HC Wainwright analyst V. Bernardino anticipates that the company will post earnings of ($0.42) per share for […]
